Macquarie Group LTD Bausch Health Companies Inc. Transaction History
Macquarie Group LTD
- $79.1 Billion
- Q2 2025
A detailed history of Macquarie Group LTD transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 5,100,000 shares of BHC stock, worth $35.7 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,100,000
Previous 6,600,000
22.73%
Holding current value
$35.7 Million
Previous $42.7 Million
20.46%
% of portfolio
0.04%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding BHC
# of Institutions
252Shares Held
243MCall Options Held
2.44MPut Options Held
8.42M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$243 Million2.99% of portfolio
-
Goldentree Asset Management LP New York, NY34.3MShares$240 Million23.91% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny32.8MShares$230 Million11.35% of portfolio
-
Nomura Holdings Inc Tokyo, M021.5MShares$150 Million0.31% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$91 Million0.18% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.53B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...